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Abstract
Background: In Europe, the number of females exhibiting oppositional defiant disorder (ODD) and conduct
disorder (CD) is growing. Many of these females live in youth welfare institutions. Consequently, there is a great
need for evidence-based interventions within youth welfare settings. A recently developed approach targeting the
specific needs of girls with ODD and CD in residential care is START NOW. The aim of this group-based behavioural
skills training programme is to specifically enhance emotional regulation capacities to enable females with CD or ODD
to appropriately deal with daily-life demands. It is intended to enhance psychosocial adjustment and well-being as well
as reduce oppositional and aggressive behaviour. We present the study protocol (version 4.1; 10 February 2016) of the
FemNAT-CD intervention trial titled ‘Group-Based Treatment of Adolescent Female Conduct Disorders: The Central Role
of Emotion Regulation’.
Methods/design: The study is a prospective, confirmatory, cluster-randomised, parallel-group, multi-centre,
randomised controlled trial with 128 institutionalised female adolescents who fulfil the diagnostic criteria of ODD
and/or CD. Institutions/wards will be randomised either to provide the 12-week skills training as an add-on intervention
or to provide treatment as usual. Once the first cycle is completed, each institution will run a second cycle with the
opposite condition. Primary endpoints are the pre-post change in number of CD/ODD symptoms as assessed by a
standardised, semi-structured psychiatric interview (Kiddie Schedule for Affective Disorders and Schizophrenia
for School-Age Children–Present and Lifetime, CD/ODD section) between baseline and the end of intervention, as well
as between baseline and a 3-month follow-up point. Secondary objectives include pre-post change in CD/ODD-related
outcome measures, most notably emotional regulation on a behavioural and neurobiological level after completion of
START NOW compared with treatment as usual.
Discussion: To our knowledge, this study is the first to date to systematically investigate the effectiveness of an adapted
integrative psychosocial intervention designed for female adolescents with ODD and CD in youth welfare settings.
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Background
Across European countries, an increase in mental health
problems, along with a growing rate of violence and
aggression in youths, can be observed [1]. Children and
adolescents with conduct problems, including aggres-
sion, represent a highly heterogeneous group. From a
diagnostic perspective, aggressive and oppositional
behaviour has been subsumed under the diagnoses con-
duct disorder (CD) and oppositional defiant disorder
(ODD) [2]. The heterogeneity is reflected not only by a
great variety of symptoms ranging from impulsive, hot-
tempered quarrels or stealing to acts of cruelty to ani-
mals or people but also by the extent of co-morbidity
(e.g., attention-deficit disorder, depression, anxiety disor-
ders, learning difficulties, posttraumatic stress disorder).
Furthermore, research indicates that especially children
and adolescents with ODD and CD bear a high risk for
maladjustment and the persistence of aggressive and
antisocial behaviour symptoms into adulthood [3–6]. In
that sense, youth with ODD or CD represent a highly
vulnerable group with a significant risk and cost, not
only to themselves but also to their immediate sur-
roundings and ultimately to society as a whole.
Although especially CD has long been considered a
male-typical disorder (with male-to-female prevalence
ratio estimates ranging from 2:1 to 8:1 [7]), recent re-
search suggests rising and rather high prevalence rates
of about 1–3% among girls and female adolescents [8–
10]. Conduct problems (including ODD or sub-clinical
symptoms) are observed in approximately 14% of girls
and 16% of boys in Europe [11]. Not surprisingly, preva-
lence rates of specific populations, such as incarcerated
females, are considerably higher, ranging between 32%
and 73% [12]. Although the number of females exhibit-
ing ODD and CD is growing, the majority of studies on
therapeutic treatment options for CD have been focused
primarily on male subjects, despite strong evidence that
the course and overall psychosocial adjustment problems
associated with CD are often more severe in females
than in males [7, 13]. Sequelae such as school failure,
substance abuse, delinquency, child prostitution, and
early pregnancy (often associated with poor parenting
skills) pose serious problems on an individual as well as
a societal level.
The development of ODD and CD is generally seen to
be caused by an interplay between adverse psychosocial
and neurobiological factors that can ultimately result in
severely impaired emotional regulation capacities [14].
Patients with ODD and patients with CD are charac-
terised predominantly by impulsive-aggressive behaviour
that is often associated with high emotional vulnerability
exemplified by hypervigilant behaviour in response to
neutral stimuli. In addition, patterns of thought that
include automatic appraisals and distortions of attribu-
tion are often found. On top of that, adolescents with
conduct problems frequently experience interpersonal
difficulties, which are oftentimes associated with high
levels of psychological distress. For these youth, a thera-
peutic approach focused on stress tolerance, mindful-
ness, emotional regulation, interpersonal skills and
adequate handling of emotions is well-suited and
directly tailored to their needs [15]. As for a specific
sub-group of adolescents with CD that can be best
described as callous-unemotional with associated features,
such as a lack of emotional responsivity, lack of empathy,
extreme patterns of thought (e.g., black-and-white think-
ing), and interpersonal difficulties without any associated
psychological distress, different kinds of therapeutic strat-
egies seem to be needed. Here, interventions focused on
enhancing empathic capacities, moral reasoning and
perspective-taking are required [15]. So far, research indi-
cates that, next to individual skills training, adolescents
with ODD/CD benefit immensely from therapeutic
approaches that involve their direct environment [16, 17].
More specifically, children with disruptive behaviours pri-
marily benefit from parent-focused interventions, whereas
adolescents with externalising behaviours respond very
well to multi-modal approaches [16].
The intervention
One specific approach that has accumulated support for
use with forensic patient populations and appears very
suitable for the treatment of female adolescents with
ODD/CD is START NOW [18]. Developed at the
Department of Correctional Managed Health Care,
University of Connecticut, USA, the skills programme
was evaluated at multiple correctional facilities through-
out the State of Connecticut [18]. In its original format,
START NOW is a manualised, group-based skills train-
ing programme designed for use within correctional
institutions. The focus of the intervention is on (1) in-
creasing self-control over impulses, (2) enhancing
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emotion recognition and regulation, (3) making judge-
ments and decisions on the basis of consequences
and (4) improving stress management and coping
skills [19]. START NOW is an integrative evidence-
informed intervention based on several therapeutic
approaches. These therapeutic elements were chosen
because of research findings as well as suitability for
the target population (i.e., patients with behaviour
disorders) and for integration with other aspects of
the planned treatment. More specifically, the
programme combines aspects of cognitive behavioural
therapy (CBT), motivational interviewing (MI),
dialectical behaviour therapy (DBT) and trauma-
sensitive care. The subsequent sections outline the
different elements that comprise START NOW in
more detail and elaborate on their relevance with
regard to the target population.
Cognitive behavioural therapy
CBT represents the theoretical underpinning of the
intervention. The programme integrates functional
analysis to help group members break down behaviour
patterns and understand their own behaviour in the con-
text of its antecedents and consequences. In addition,
CBT serves to help patients understand how their own
conceptualisation of events is connected to their mood
and behaviour. Understanding these cognitive processes
increases patients’ control and understanding of their
behaviour. Furthermore, it facilitates recognition and
coping with potential triggers, the modification of cogni-
tions and attitudes, as well as the replacement of prob-
lematic behaviours with alternate conduct. Within the
CBT framework, new skills are being taught and prac-
ticed within as well as between sessions (including role-
playing, problem-solving, group discussions or practice
exercises) to facilitate transfer [20].
A meta-analysis of outcomes from 26 research articles
addressing the effectiveness of group therapy with adult
offenders [21] revealed positive effects of CBT, including
improved interpersonal functioning, improved self-
esteem and anger management, as well as a decrease in
feelings of anxiety and in disciplinary sanctions. There is
also long-standing support for using CBT-based ap-
proaches with adolescents who exhibit externalising
problem behaviours [22–25]. Furthermore, evidence sug-
gests that a therapeutic group approach incorporating
practical issues in daily-life situations is well-accepted in
adolescents and may show high effectiveness even in se-
verely aggressive youth [26]. In addition, CBT has been
shown to be feasible for use with counsellors: A training
programme using treatment manuals resulted in highly
skilled implementations, high levels of counsellors’ self-
reported confidence to use the intervention effectively,
and high satisfaction ratings [27].
Motivational interviewing
MI forms an additional part of the START NOW
programme. It is seen as a useful complement to CBT
because it represents a client-centred approach that dir-
ectly addresses a patient’s ambivalence and facilitates
motivation for change [28]. In this sense, MI helps to
provide the basis for the patient’s willingness to engage
in the intervention [29, 30], whereas CBT provides the
specific tools and strategies to change problematic be-
haviours. Adolescents with ODD or CD do not tend to
show much insight into the degree of inadequacy of
their misconduct and as a result do not present with a
great motivation for change. Therefore, a therapeutic
stance that is marked with validation and empathy on
the one hand, and the exploration of dysfunctional be-
haviours and their associated negative consequences on
the other hand, is a feasible treatment strategy also for
the treatment of adolescents with disruptive behaviour
disorders [31]. START NOW uses several MI aspects,
such as the view that ambivalence toward change is
common and normal. Furthermore, discussions and
exercises stimulating change talk and designed to over-
come potential ambivalence are provided. Finally, self-ef-
ficacy and positive behaviours are evoked and reinforced
throughout the whole intervention [32].
In the past, there have been other effective interven-
tions that have combined the two approaches [33, 34].
The literature reveals positive indications for the use of
MI with adolescents: Effects have been found in the
areas of substance use [35, 36], weight-related problems
[37, 38] and diabetes [39]. In a cluster-randomised trial
investigating the effectiveness of single-session MI
intended to reduce adolescent substance use behaviour,
for instance, researchers found moderate to large effect
sizes [36]. Furthermore, MI has been linked to better
treatment retention rates mostly in adult populations in
various settings [40–42].
Cognitive modifications
Because the original format was designed for use with
correctional populations, the developers decided to
include cognitive modifications of the regular clinical
approach in response to studies indicating that high
numbers of incarcerated individuals have sustained
traumatic brain injuries (TBIs) [43], as well as studies re-
vealing low effectiveness of interventions that do not
take such impairments into account [44]. Regarding the
presence of TBI in adolescents exhibiting disruptive be-
haviour disorders, research has shown high prevalence
rates [45]. In a study of the incidence of TBI among 720
delinquent adolescents in youth services institutions
throughout the State of Missouri, USA, investigators
found incidence rates of self-reported lifetime TBI as
high as 18.3%, meaning nearly one in five adolescents
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reported having sustained a TBI at some point in their
lives [45]. Because TBI has been linked to reduced verbal
capacities, school problems and concentration problems
[46], START NOW was designed to address such limita-
tions by using participant workbooks written at a fifth-
grade reading level, with little jargon, using many
pictures and repetitions of key concepts and integrating
a lot of practice exercises and group discussions to
enhance understanding and recollection.
Dialectical behaviour therapy
START NOW further includes some principles that are
compatible with DBT. The therapy, which was originally
developed for patients with borderline personality
disorder [47], has been increasingly applied to forensic
sample populations living in residential care settings or
correctional facilities [48, 49]. Fundamental to the devel-
opment of DBT is a biosocial theory that conceptualises
a patient’s emotional dysregulation as the result of a
biological tendency toward emotional vulnerability in
conjunction with an invalidating rearing environment
[50]. Within START NOW, two key concepts of DBT
are found: (1) emphasis on dialectics and (2) mindful-
ness. The balance between validation and confrontation
mainly represents the so-called dialectical relationship
work that can also affect the degree of motivation for
change as well as the willingness to explore new behav-
iour patterns [51]. Mindfulness stemming from Eastern
spiritual practices was first and innovatively combined
with CBT strategies within DBT [52]. Within START
NOW, a subset of mindfulness exercises is offered, ran-
ging from interactive exercises to inner mindfulness
practices that involve paying close attention to one’s
own body. Adolescents are encouraged throughout the
programme to try each type of exercise and decide for
themselves what kind of mindfulness practice best works
for them.
Applying DBT strategies to settings where there is a
high prevalence of ODD and CD is highly reasonable
because this target population shows many of the same
risk factors for the development of emotion dysregula-
tion as do borderline patients [49, 53]. The first evidence
that DBT is likely to be effective in females with CD
symptoms has already been shown [54–56]. Nelson-
Gray and colleagues [54], for instance, found significant
reductions in externalising and internalising symptoms
in an outpatient sample of youth with ODD. With re-
gard to mindfulness specifically, a randomised controlled
trial with 228 non-clinical first- to third-grade students
showed significant improvements in terms of text anx-
iety, social skills and selective attention [57]. The use of
mindfulness techniques with adolescents with externalis-
ing problems has also been investigated in a handful of
studies, and to date the results are encouraging, with
small to medium effect sizes, with regard to aggressive,
non-compliant acts; social behaviour; attention; and sub-
jective happiness [58–60].
Trauma-sensitive care
START NOW integrates aspects of trauma-sensitive
care. This approach includes the central idea that
dysfunctional behaviour can emerge as a result of an
individual’s adjustment to adverse, highly stressful life
circumstances. In this sense, many kinds of currently
problematic behaviours may be understood as initially
adaptive coping strategies in response to negative situa-
tions. In the long term, however, those adaptive strat-
egies may become associated with a preponderance of
negative consequences. START NOW specifically uses
some concepts of Trauma Affect Regulation: Guide for
Education and Therapy [61], including focusing
exercises as well as self-monitoring. Research indicates
that adolescents in residential care settings represent a
population with a high incidence of trauma histories and
trauma symptoms. In one study of different types of
maltreatment experiences over and above the incidence
of conduct problems in female adolescents in out-of-
home care, researchers identified a large proportion of
the sample reporting severe to extreme maltreatment
experiences, ranging from 20% for sexual abuse to 33%
for emotional abuse [62]. Furthermore, these maltreat-
ment experiences were shown to be connected to
trauma-related symptoms in emerging adulthood. These
findings speak to the relevance of using trauma-sensitive
interventions for maltreated adolescents to help them
connect their current symptoms with traumatic past
experiences.
The context
From the perspective of the social worker, adolescents’
behavioural dysregulation and persistent tendency to test
boundaries, along with their lack of insight into their
problematic situation, trigger anger, disappointment
and helplessness [53]. It is therefore necessary to
introduce a multi-modal concept that integrates all
involved professions and parties to enhance communi-
cation, transparency and support and to decrease stress
levels that originate from the challenges of dealing with
adolescents with ODD/CD [53]. Because of the decreased
chance of generalisation of the taught skills, in vivo coach-
ing seems most adequate to help ensure that youth with
ODD and CD will practice newly introduced strategies
consistently in daily-life situations [15]. Unfortunately, to
date, there is no study in which researchers have specific-
ally investigated the effectiveness of a skills training
programme combining the above-listed therapeutic
elements for the treatment of institutionalised female
adolescents with ODD or CD.
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Effectiveness of START NOW
A treatment evaluation study of the original START
NOW intervention in the United States showed that this
approach is effective for difficult-to-manage, impulsive
and aggressive detainees [63]. Analyses of a mixed-gender
sample of inmates (n = 946 participation events) indicated
that START NOW was effective in reducing the number
of disciplinary reports received. More specifically, a
dose-response relationship was found: Zero-inflated nega-
tive binomial regression analyses indicated that each
additional session was associated with a 5% reduction in
the incidence rate of disciplinary infractions. Furthermore,
participation in the skills training yielded high satisfaction
rates and reduced psychiatric hospitalisation days [19, 64].
It was therefore concluded that the intervention
programme represents a viable treatment option for redu-
cing problem behaviour in incarcerated populations.
The present study
Within the framework of the FP7 project Neurobiology
and Treatment of Adolescent Female Conduct Disorder:
The Central Role of Emotion Processing (FemNAT-CD;
see http://www.femnat-cd.eu/ for more information), a
European multi-disciplinary study, the aim of the present
study is to evaluate the effects of an adapted, gender-
specific START NOW intervention for females with
ODD/CD living in youth welfare institutions. To our
knowledge, no prior study has evaluated the effects of
such a CBT-based intervention combining aspects of
multiple other therapeutic approaches for this specific
population in the youth welfare sector. The adaptation of
the original START NOW intervention still employs the
same underlying principal components of the skills train-
ing, but it uses a slightly modified framework (i.e., individ-
ual sessions on top of group sessions to enhance personal
understanding and relevance of content; shortened length
of the programme due to frequent temporary, time-
constrained placements) and adjusted content (i.e., illustra-
tions and theme stories tailored to teenage girls’ interests).
Furthermore, the intervention will be conducted by staff
members of the respective youth welfare institution. Inten-
sive pre-training and supervision, including fidelity
monitoring, will be provided. The intervention comprises
weekly group sessions (14 sessions, 90 minutes each) and
individual sessions (45 minutes each). The aim of the indi-
vidual sessions is to ensure the transfer of the content of
the group training into the personal, daily routines of the
participants. Girls are encouraged to practice the skills
introduced during the START NOW training between ses-
sions in their daily social interactions with the aid of the re-
sponsible social worker. In addition, parents will be sent
information on START NOW and information regarding
efficient parenting strategies and communication skills with
adolescents. In essence, key aspects of the START NOW
skills training have remained the same within the
adapted version and are well-suited for the target
population that can, similarly to the target population
of the original format, be described by emotional
regulation deficits, many invalidating and traumatic
relationship experiences, high impulsivity and a low
motivation for change.
Hypotheses
On the basis of the literature, it is hypothesised that
female adolescents participating in the add-on START
NOW programme will show a greater reduction of
aggressive symptoms and co-morbid psychopathology as
well as enhanced emotional regulation as compared with
adolescents undergoing treatment as usual (TAU). The
primary outcome measure refers to the change in number
of ODD/CD symptoms endorsed over time as assessed
using a semi-structured psychiatric interview (Kiddie
Schedule for Affective Disorders and Schizophrenia for
School-Age Children–Present and Lifetime [K-SADS-PL],
sections ODD/CD) with the female adolescent and her
respective social worker.
Regarding secondary outcomes, it is hypothesised that
START NOW will result in a reduction of co-morbid
psychopathology and an enhancement of life satisfaction
and emotional regulation skills compared with TAU
alone. The predictive value of psychosocial and neuro-
biological as well as specific personality variables will be
investigated. The question of who benefits most from
intervention programmes (and who does not) is of major
interest to offer effective and tailored intervention strat-
egies. There is accumulating evidence that patients with
CD with elevated callous-unemotional traits profit less
from current interventions [14, 65]. This might be due
to a biologically determined hyporesponsiveness to
distress cues that might interfere with social learning
[66]. We thus hypothesise that reduced emotional re-
sponsiveness/elevated callousness is predictive of low
intervention success in females with CD/ODD. Accord-
ingly, we will focus on change in heart rate variability
(HRV) because HRV has been identified as an important
correlate of emotional regulation difficulties and treat-
ment response [67]. In addition, in a sub-sample, we will
evaluate change in neural functional correlates using a
functional paradigm specifically assessing emotional
regulation capacities under emotionally distressing con-
ditions [68–71]. Further, we expect that the intervention
comprising staff training and regular supervision will re-
duce self-reported stress and symptoms of burn-out in
involved social workers.
Methods/design
The present study is a prospective, confirmatory,
cluster-randomised, multi-centre, international phase III
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trial with two parallel groups (intervention vs. TAU) and
three trial phases (baseline assessment, 12 weeks of
treatment, 12 [±1] weeks of follow-up observation). The
intervention condition is incorporated into the usual
standard care within residential care (START NOW+
TAU) vs. TAU. A randomised controlled AB-BA design
will be used. Institutions will be randomised to start
either with the intervention group (A) or with the
control group (B) (TAU). After having conducted A or B,
each institution will run the other condition: Institutions
starting with TAU receive START NOW, and institutions
that finished START NOW and the follow-up assess-
ment conduct a new group with TAU, whereby strict
rules are defined to eliminate the risk of carry-over
effects.
Study centres
The study will take place at youth welfare institutions
located in proximity to four clinical trial centres. Study
centres include the departments of child and adolescent
psychiatry at the university hospitals in Basel, Switzerland
(CS, principal investigator); Frankfurt, Germany
(CMF); Aachen, Germany (BHD); and Amsterdam,
The Netherlands (AP). Data management as well as
biometric and statistical support are provided by the
Institute of Medical Biometry and Informatics (IMBI),
University of Heidelberg, Germany. The Coordination
Centre for Clinical Trials (Koordinierungszentrum für
Klinische Studien [KKS]) at the University of Heidelberg
is in charge of study monitoring.
Participants
Several youth welfare institutions will be asked to partici-
pate. If they agree, female adolescents in the institutions
who are aged 12–20 years and their legal guardians will be
asked if they want to participate. Diagnostic assessment
will be standardised according to criteria of the Diagnostic
and Statistical Manual of Mental Disorders, Fourth
Edition, Text Revision (DSM-IV-TR) or the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition
(DSM-5). Diagnostic information is obtained via a semi-
structured clinical interview (K-SADS-PL). Inclusion and
exclusion criteria are listed in Table 1.
Criteria for withdrawal
Participants may withdraw from the study (1) at their
own request or the request of their parents/legal repre-
sentatives; (2) if, according to the investigator’s opinion,
participation in the trial would be harmful for the partic-
ipant’s well-being; or (3) if the participant’s behaviour
significantly disturbs and impedes group sessions due to,
for example, aggressive behaviour directed toward other
group members or herself.
Concomitant treatment
Additional treatments administered to the participants
on entry into the trial or at any time during the study
are documented as concomitant treatments on the
respective pages of the case report form (CRF).
Concomitant treatments are allowed in the intervention
group as well as the control group as long as they do
not represent a group-based psychotherapeutic approach.
Table 1 Inclusion and exclusion criteria
Inclusion criteria Female adolescents aged 12–20 years
Diagnosis of current CD (DSM code 312.8) and/or ODD (DSM code 313.81)
Sufficient writing and reading skills (in German or Dutch)
Exclusion criteria History or current clinical diagnosis of autism spectrum disorder according to ICD-10,
DSM-IV-TR or DSM-5 (autism, Asperger syndrome, pervasive developmental disorder-not
otherwise specified, atypical autism, autism spectrum disorder)
History of or current clinical diagnosis of schizophrenia according to ICD-10, DSM-IV-TR or DSM-5
Current clinical diagnosis of bipolar disorder or mania according to ICD-10, DSM-IV-TR or
DSM-5 (History of bipolar disorder or mania is not an exclusion criterion for individuals with CD.)
Fetal alcohol syndrome according to ICD-10, DSM-IV-TR or DSM-5
Known monogenetic disorder, genetic syndrome (e.g., fragile X syndrome, Down syndrome,
Prader-Willi syndrome)
Any chronic or acute neurological disorder (e.g., cerebral palsy, motor problems due to motor or
metabolic disorder, current treatment for epilepsy, history of severe traumatic brain injury) (Mild
traumatic head injury without loss of consciousness is not an exclusion criterion.)
Any valid indication of IQ <70 (e.g., special education, previous test results)
Severe medical condition interfering with the intervention, including suicidal ideation
Concurrent group-based psychotherapeutic treatment such as START NOW, DBT-A or similar interventions
Abbreviations: CD Conduct disorder, DBT-A Dialectical behaviour therapy for adolescents, DSM-IV-TR Diagnostic and Statistical Manual of Mental Disorders, Fourth
Edition, Text Revision, DSM-5 Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, ICD-10 International Classification of Diseases, Tenth Revision, IQ
Intelligence quotient, ODD Oppositional defiant disorder
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Examples of concomitant treatments include individual
psychotherapy or external support activities that serve to
strengthen social-emotional, cognitive or physical compe-
tencies (e.g., drama club, chess club, soccer). Medication
and changes in dosage will also be documented through-
out the study.
Measurement time points
Assessments will be conducted at baseline (T1), 6 weeks
after the start of the intervention (mid-treatment [T2]),
3 months after the start of the intervention (end of treat-
ment [T3]) and 3 months after the end of the interven-
tion (T4). The flow of participants from recruitment
through the end of the study is shown in Fig. 1. To
promote participant retention, regular contact with par-
ticipants through telephone calls, on-site visits and
information letters is provided. Furthermore, partici-
pants who discontinue the intervention but are still in-
terested in taking part in the data assessments are
nevertheless assessed. Because the number of sessions
attended is a control variable in the analysis, continuing
data collection with participants who are drop-outs is
not a problem.
Primary outcome measure
The primary outcome variable is defined as change in
number of fulfilled CD/ODD diagnostic criteria as
assessed by a standardised, semi-structured clinical
interview between baseline and post-treatment and
between baseline and follow-up. The K-SADS-PL will be
used [72, 73]. Interviewers will be trained by an experi-
enced clinician, and regular consensus meetings will be
held. The K-SADS-PL is a widely used and validated
semi-structured diagnostic interview designed to assess
current and past episodes of psychopathology in children
and adolescents according to DSM-IV-TR/DSM-5
criteria. Interviews are conducted with the adolescent as
well as with a social worker from the participant’s
Fig. 1 Trial flowchart. TAU Treatment as usual
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respective youth welfare institution who is not involved
in the intervention. Symptom measures, diagnoses and
severity ratings derived from the interview are based on
the obtained information combined with clinical judge-
ment. Thus, summary ratings are achieved by including
all sources of information.
Secondary outcome variables
Further objectives of the present trial are to assess pre-
post changes in different aggression phenotypes and
CD/ODD-related outcome measures in girls participat-
ing in the START NOW training compared with those
receiving TAU. In adolescents, the Reactive-Proactive
Aggression Questionnaire [74], used to distinguish be-
tween reactive and proactive/instrumental forms of
aggression, and the Relational Aggression Questionnaire
[75], which assesses relational aggression strategies such
as excluding members of the peer group or spreading
gossip, will be used. The Child Behaviour Checklist [76]
is used to assess various externalising (attention prob-
lems, aggression, delinquency) and internalising (e.g.,
anxiety/depression) symptoms in adolescents via self-
and parent-report. The Affective Reactivity Index (as
self-rating form and as caretaker rating) [77] is used to
capture general irritability. To assess psychopathic traits,
the Youth Psychopathic Traits Inventory [78] will be
used. Next to this self-rating questionnaire, the Inven-
tory of Callous-Unemotional Traits, Parent Report [79],
will be obtained from parents to capture change in
parent-reported callous-unemotional traits. Social
workers will rate aggression symptoms in daily-life situa-
tions with the modified Overt Aggression Scale origin-
ally developed by Yudolfsky et al. [80]. In adolescents
also, a time-sampling short assessment procedure (eco-
logical momentary assessment) will be used with mea-
sures collected twice daily (after lunch and after supper
on 4 consecutive days; pre-, mid- and post-assessment)
to capture current emotions and regulation capacities
while minimising retrospection effects and interference
with the daily routine. To assess change in deliberate
emotional regulation strategies, the Difficulties in Emo-
tion Regulation Scale [81] will be used.
Each female adolescent will define individual goals,
and their attainment will be investigated on the basis of
Goal Attainment Scaling [82]. In addition, general life
satisfaction of the adolescents [83] will be assessed with
the Brief Multidimensional Students’ Life Satisfaction
Scale. Caretakers’ self-efficacy, burn-out symptoms and
job satisfaction will be assessed with the Burnout
Screening Scale, a composite instrument comprising dif-
ferent questionnaires [84–88]. In the intervention group,
the clients’ and trainers’ satisfaction with the programme
will be assessed (Client Satisfaction Questionnaire/
Training Satisfaction Questionnaire) [19].
Moderators of outcome measures
Several potential moderators of the outcome variables will
be assessed. The Massachusetts Youth Screening Instru-
ment version 2 [89] is a self-report questionnaire that
screens for a multitude of behaviour problems and poten-
tial emotional distress. The Pubertal Development Scale
[90] is used to assess pubertal stage using words, rather
than pictures, in those participants aged 12 years and
above. The Social and Health Assessment scales [91]—
specifically the subscales that relate to peers and neigh-
bourhood environment, but also those that assess alcohol
and drug use, bullying and future outlook—are used in the
present study. To assess intelligence quotient (IQ), two
sub-tests of the Wechsler Intelligence Scale for Children,
Fourth Edition [92], or the Wechsler Adult Intelligence
Scale, Fourth Edition, are performed with the adolescents:
vocabulary as a measure of verbal comprehension and
matrix reasoning to examine perceptual reasoning capacity.
The Diagnostic Interview for DSM-IV Personality Disorders
(Axis II [93]) is a semi-structured diagnostic interview
done to assess the ten DSM-IV personality disorders. In
the present study, a sub-section is used to assess bor-
derline personality disorder symptoms. The quality of
the youth welfare institution is systematically assessed
through use of the Institutional Quality Index (IQI). The
Treatment as Usual Questionnaire (TAU-Q) is distributed
to assess the youth welfare institution’s standard care. Both
the IQI and TAU-Q were developed specifically for the
purpose of the present study. The Childhood Experience
of Care and Abuse Questionnaire [94] is a self-report
questionnaire that was developed to mirror an existing
validated interview measure: the childhood experience
of care and abuse. The questionnaire assesses lack of
parental care (neglect and antipathy), parental physical
abuse, and sexual abuse from any adult before age 17 years.
Information regarding pre-natal and peri-natal risk fac-
tors for antisocial behaviour, such as maternal smoking
in pregnancy, post-natal depression and negative living
conditions in early life, as well as the socio-economic
status, is additionally assessed during a standardised
interview with primary caregivers. For a detailed overview
on measurement time points/trial schedule, please refer
to the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) checklist shown in Fig. 2.
For a detailed overview on information given within this
protocol please consult (Additional file 2).
Neurobiological measures of emotion processing
Neuropsychological correlates
The emotional go/no go task [95] will be used to
examine regulation under multiple emotional condi-
tions, including positive, negative and neutral facial
expressions. With the Passive Avoidance Learning
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TRIAL SCHEDULE
Informant: 
A – adolescent 
C – caretaker
P - parent
















≤ 4 (+2)weeks 
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intervention
≤ 2 weeks after 
end of 
intervention






























CBCL/YSR4 ● ● ● ● ● ●
DERS ● ● ● ●
YPI ● ●
ICU ● ● ●
Informant: 
A – adolescent 
C – caretaker
P-parent
















BMSLSS ● ● ● ●
GAS-S, GAS-P ● ● ● ● ● ●
ARI-S, ARI-P ● ● ● ●
M-OAS5 ● ● ●
I-EMA5 ● ● ●
BSQ ● ●
Neuropsychological, neurophysiological measures and real life data:
Neuro-psychol. 
test battery6 ● ●
Neuro-physiol. 
test battery7 ● ● ●




Concomitant Intervention and satisfaction measures:
QAF10 ●
CSQ/TSQ ● ● ●
IQI ●
TAU-Q11 ● ● ● ●
Fig. 2 (See legend on next page.)
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Test, we intend to assess stimulus-reinforcement
learning (adapted from [96]).
Autonomous correlates
Autonomous correlates will be measured as part of a
neuropsychological test battery. Basal autonomic ner-
vous system (ANS) parameters will be measured during
a 5-minute resting protocol [97]. ANS reactivity will be
measured during a countdown task [98] and while
watching emotion-evoking film clips [99]. Especially
HRV seems to be a promising indicator of treatment
success [67, 100].
Neural correlates
Neural correlates will be studied using functional and
structural magnetic resonance imaging at baseline.
Changes in these neural correlates will be investigated
(in a sub-sample post-intervention in Basel and Aachen
only) as mechanisms underlying the brain’s adaptation
to treatments likely related to both structural plasticity
and functional response alterations [101].
Genetic functional variants
Genetic functional variants in saliva (serotonergic, norad-
renergic, dopaminergic, neuropeptide) will be investigated
to test the hypothesis that specific functional genetic vari-
ants are predictive of low intervention success.
Sample size calculation and statistical analysis
The sample size calculation is based on the primary effi-
cacy endpoint ‘pre-post treatment change in number of
fulfilled CD/ODD diagnostic criteria’ after the 12-week
group-based START NOW training programme for
female adolescents (as add-on therapy to TAU) com-
pared with TAU only within youth welfare institutions.
On the basis of results reported by Nelson-Gray et al.
[54], pre-post changes in the treatment group of μ = 3
and in the control group of μ = 1, as well as a conserva-
tive common standard deviation of 3.5 for both groups,
are expected. Because the Nelson-Gray et al. study inter-
vention comprised only 1 DBT training module and only
16 sessions instead of 14 group sessions + 12 individual
sessions as in our study, compared with the change of
2.24 in the Nelson-Gray study, we expect at least μ = 3.
In addition, it has to be assumed that TAU in youth
welfare settings will also result in reduction of ODD/CD
symptoms. Owing to the group therapy and the respect-
ive appropriate randomisation procedure, we will have a
correlated data structure. To account for that, a design
effect of 1.08 to adjust for intra-group correlation of
0.02 is assumed. To achieve a power of 80% (α = 5%,
two-sided; two-sample t test), a total of 108 patients is
required for the analysis. Therefore, 172 patients will be
assessed for eligibility to obtain 128 patients to be
randomised (assuming that 25% of screened patients are
not eligible). A drop-out rate of 15% is expected (includ-
ing major protocol violations and loss to follow-up). The
problem of missing values is partly resolved in the
confirmatory analysis by application of an imputation
strategy. Nevertheless, another 15% of patients will be
randomised to compensate for the loss of information
caused by drop-outs and loss to follow-up. The sample
size calculation was done using nQuery Advisor 7.0 soft-
ware (Statistical Solutions, Cork, Ireland).
Statistical methods
The full analysis of the primary outcome measure will
be conducted on the basis of the intention-to-treat (full
analysis set) population, including all randomised pa-
tients. To account for the data structure, a linear mixed
model with the primary endpoint (change in ODD/CD
score between baseline and end of intervention) as the
response variable, including baseline CD/ODD symp-
toms, group, age, site and IQ as fixed factors and the
respective cluster as a random factor, will be applied.
The random intercept, as well as the residuals, will be
assumed to be normally distributed. The correlation
structure can be referred to as compound symmetry
[102], which is a common assumption in cluster-
randomised trials [103]. The results will be presented as
the mean between-group difference with the corre-
sponding two-sided 95% confidence interval. The associ-
ated Hedges’ effect size g [104] will be calculated, in
addition to the practice-related intra-cluster correlation
coefficient. To fit the primary model, the restricted
maximum likelihood approach will be used.
(See figure on previous page.)
Fig. 2 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) checklist for the trial. ANS Autonomic nervous system, ARI
Affective Reactivity Index, BMSLSS Brief Multidimensional Students’ Life Satisfaction Scale, BSQ Burnout Screening Scale, CBCL Child Behaviour
Checklist, CD Conduct disorder, CECA-Q Childhood Experience of Care and Abuse Questionnaire, CSQ Client Satisfaction Questionnaire, DERS
Difficulties in Emotion Regulation Scale, DIPD-IV Diagnostic Interview for DSM-IV Personality Disorders, EMA Ecological momentary assessment,
fMRI Functional magnetic resonance imaging, GAS Goal Attainment Scaling, HR Heart rate, HRV Heart rate variability, ICU Inventory of
Callous-Unemotional Traits, IQ Intelligence quotient, IQI Institutional Quality Index, K-SADS-PL Kiddie Schedule for Affective Disorders and
Schizophrenia for School-Age Children–Present and Lifetime, MOAS Modified Overt Aggression Scale, ODD Oppositional defiant disorder, QAF Quality
Assurance Form, RSA Respiratory sinus arrhythmia, SCL Skin conductance level, SCR Skin conductance response, T1, T2, T3, T4 Time points 1, 2, 3 and 4,
TAU Treatment as usual, TAU-Q Treatment as Usual Questionnaire, TSQ Training Satisfaction Questionnaire, WAIS Wechsler Adult Intelligence Scale,
WISC-IV Wechsler Intelligence Scale for Children, Fourth Edition, YPI Youth Psychopathic Traits Inventory, YSR Youth Self-Report
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The overall type I error rate is set at α = 5% (two-
sided) and will be controlled by applying the multiple
test procedure for hierarchically ordered hypotheses.
The first null hypothesis states that the change in ODD/
CD score between baseline and end of intervention is
equal for both the intervention and control groups (H0I:
μ1I = μ2I). This hypothesis will be tested at a two-sided
level of significance of 5% against the alternative hypoth-
esis (H1I: μ1I ≠ μ2I). Only if the first hypothesis can be
rejected will the second null hypothesis, which states
that the change between baseline and follow-up
(12 weeks after end of intervention) will be equal in both
groups (H0II: μ1II = μ2II), be tested in the same way. This
second hypothesis can then be tested also at a two-sided
level of significance of 5% against the alternative hypoth-
esis (H0II: μ1II ≠ μ2II). Application of this multiple test
procedure for hierarchically ordered hypotheses assures
control of the overall type I error rate of 5%. Both null
hypotheses will be tested by applying a random effects
model that includes baseline CD/ODD symptoms,
group, age, institution and IQ as fixed factors and cluster
as a random factor. This statistical analysis plan was spe-
cified before the opening of the database.
Methods against bias
Eligibility assessment, obtaining informed consent and en-
rolling the participants in the trials are performed at each
trial site by one of the local investigators. Institutions will
be randomised to start with either the intervention group
or the TAU control group. The institutions will be rando-
mised in fully eligible groups (group size of four to eight
participants), stratified by site using a centralised web-
based tool (http://www.randomizer.at [14 Jan 2013], Med-
ical University of Graz, IMBI, Statistics and Documenta-
tion, c/o Prof. Andrea Berghold). The randomisation tool
is supervised by the IMBI at the University of Heidelberg,
Germany.
Screening and baseline assessment are performed be-
fore the randomisation procedure, so that data obtained
at intake are blinded with regard to group membership.
Furthermore, all interviews will be conducted with
someone who is not involved in the training.
To ensure that START NOW is implemented in all
residential institutions in a comparable way, all staff
trainers are trained before the beginning of the study
and have to pass a practical and written test. The 2-day-
long pre-training will be conducted after randomisation
and before the start of the intervention. To increase
treatment adherence, a facilitator manual with a detailed
session-by-session outline will be used next to the work-
book for adolescents. The application of the modularised
sessions is strictly monitored. In addition, trainers are
supervised by START NOW facilitators every other
week during the intervention period. To assess
adherence and competence, two training sessions of
the programme (one in unit 1, one in unit 2) will be
either directly attended by one START NOW super-
visor or videotaped. The quality check (Quality Assur-
ance Form [QAF] [19]) will be focused on adherence
to the content of the programme and basic trainer
competencies (use of motivation interviewing, rolling
with resistance, validation).
With regard to the trial design, institutions that were ran-
domised to start with the intervention condition first and
subsequently provide a second cycle of TAU have to fulfil
two conditions to eliminate potential carry-over effects:
1. Only social workers are involved who have not been
previously trained and an exchange on START
NOW content between girls is unlikely because of
rare opportunity.
2. In case girls who participated in START NOW
remain in the institution in the same living group
after the whole cycle has ended, the time interval
between the end of an intervention group and a
second cycle of TAU is longer than 6 months.
Data quality is continuously monitored by the data
management team (IMBI), University of Heidelberg, and
the KKS). Data will be entered electronically at each
local study centre site. Range checks for data values are
done to promote data quality. Clinical monitors inspect
subject-related data during on-site visits to ensure that
all data are correct, complete and gathered according to
data protection laws.
The original study forms will be kept at the trial site.
Participants’ files are stored in locked cabinets, and
access to the study data will be restricted. Data will be
collected, processed and stored according to the data
protection laws.
Safety and ethical issues
Research activities within the FemNAT-CD START
NOW project will be carried out in compliance with the
fundamental ethical principles stated in the Declaration
of Helsinki. The KKS, an institution that is independent
from other trial staff and experienced in monitoring
psychotherapy trials, will monitor the study, adapted to
good clinical practice guidelines as stated by the
International Conference on Harmonisation of Technical
Requirements for Registration of Pharmaceuticals for
Human Use, and KKS has approved the standard operat-
ing procedures. The trial (protocol version 4.1) has
received approval from the local ethics committees at the
University of Basel (reference EKNZ 2014/075), the
University of Frankfurt (445/13 – version 5), the University
of Aachen (EK 037/15) and the University of Amsterdam
(2014.581-NL52038.029.14).
Kersten et al. Trials  (2016) 17:568 Page 11 of 16
Any modification to the protocol will require a formal
amendment and approval by each local research ethics
committee. The protocol must be agreed upon by the
trial steering committee (principal investigators at the
Department of Child and Adolescent Psychiatry, University
of Basel, and local investigators at the University of
Frankfurt, University of Aachen and University of
Amsterdam) and the data management team (KKS
and IMBI) at the University of Heidelberg.
Participants will be enrolled only after they have
received comprehensive information from the respon-
sible investigator. Participants and their parents/legal
representatives will also receive information sheets and
will have the opportunity to discuss the trial with the in-
vestigator. Written informed consent for the study will
be obtained by the investigator from all participants and
their parents/legal representatives who are willing to
participate in the trial. An example consent form is pro-
vided (see Additional file 1). All participants will be in-
formed that they can stop participating in the study at
any time without having to give justification. Participants
are provided with the right to have their information re-
moved from the database at any time. Because TAU is
allowed for both the intervention the control groups,
and because the control group will subsequently
undergo the intervention condition, participants in ei-
ther group do not experience any disadvantage with re-
gard to group allocation in relation to clinical
intervention. Control subjects who leave the institution
before the start of the intervention condition are given
the opportunity to participate in an outpatient START
NOW group. Results will be published regardless of the
magnitude or direction of the effect and will follow
Consolidated Standards of Reporting Trials (CONSORT)
and its extension 5 to cluster-randomised trials.
An independent data and safety monitoring board
(DSMB) including three independent clinical experts
and one biometrician is established to monitor the pro-
gress of the trial and ensure adherence to protocol.
Safety parameters include that all serious adverse events
(SAEs) or adverse events reported by the subject or
detected by the local investigator that occur during the
trial and all noticeable problems must be documented in
the CRF. In case of an SAE, the ethics committee will be
informed within 7 days after the SAE has been reported.
In addition, the DSMB will also be regularly informed.
In case of a significant preponderance of SAEs that
might causally be associated with the trial, the DSMB
will terminate the trial. Patients who are enrolled in the
study are covered by indemnity for negligent harm by
study insurance policies.
To guarantee confidentiality and anonymity, all partic-
ipants are allocated consecutive participant identification
(ID) numbers. The local principal investigator of each
study site will maintain a subject ID list (participant ID
codes with the corresponding participants’ names) to
enable records to be identified. Authorised persons may
inspect the subject-related data collected during the trial,
ensuring compliance with the data protection law (in-
spectors, monitors, auditors). Only encoded data will be
stored (centre code and consecutive ID number). Saliva
samples will be stored for 30 years. Data identifying a
person will be available only at the local sites. All data
collected in the online database will be managed in a
safe and secure environment. The system used for data
management is validated and is compliant with U.S.
Food and Drug Administration regulations (21 CFR part
11). All data transmission is encrypted with Secure
Sockets Layer (SSL) technology. All changes to data are
logged with computerised timestamps in an audit trail
which includes the name of the author/editor, the date/
time of the change, a reason for the change and the new
information. The IMBI Heidelberg database server with
the stored data is located in a secure data centre of the
university and is protected by a firewall. The system pro-
vides an infrastructure to support user roles and rights.
Only authorised users are able to enter or edit data, and
access is restricted to data of the subjects in the respect-
ive centre.
Discussion
This study protocol presents a randomised controlled
trial testing the effectiveness of an adapted version of a
cognitive behavioural skills training programme, START
NOW, in institutionalised females with a diagnosis of
ODD and/or CD. To date, to our knowledge, the study
represents the only randomised controlled trial of the
efficacy of the START NOW intervention specifically de-
signed for female adolescents with disruptive behaviour
problems within youth welfare institutions. There is an
internationally recognised lack of randomised controlled
studies investigating the efficacy of integrative thera-
peutic approaches [48, 49]. Consequently, the present
study gives profound consideration to the repeatedly
formulated necessity to develop integrative intervention
approaches deriving from sound theoretical rationales,
addressing core deficits of patients with ODD and pa-
tients with CD, and applying gender-specific strategies
and materials. On the basis of convincing evidence that
emotion processing is severely affected in ODD and CD,
the presented approach, focused on enhancing emo-
tional regulation and interpersonal capacities, is well-
suited for this target group.
There is a specific need to implement and evaluate
intervention approaches in settings where most of the
affected adolescents live, most notably in residential care
settings [105, 106], because residential treatment by itself
seems not sufficiently effective in reducing externalising
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symptoms [107]. Effective treatment of severely aggres-
sive, rule-breaking and unit-destructive behaviour is cru-
cial to the safe operation of the residential environment
[53]. This is of major relevance for staff workers dealing
with adolescents who experience severe behavioural and
emotional dysregulation. Thus, the implementation of
evidence-based intervention approaches within youth
welfare institutions is needed to strengthen the chance
of continuous care and to avoid repeated relationship
break-offs in severely affected adolescents living in these
settings [107]. As such, the results of the present study
shall be of high relevance for residential care settings
and shall evoke further debates over, if not directly en-
hance, the standard of care provided within the youth
welfare sector.
Essential methodological issues will be considered to
manage threats to internal validity on the outcome of
the present randomised controlled trial [108]. START
NOW is manualised, and all facilitators receive 2 days of
rigorous, standardised training. Beyond an in-depth
preparation, START NOW’s implementation will be
checked via regular fidelity monitoring assessed by the
respective supervisor through use of a standard QAF.
The study is large enough to determine the presence of
clinically important effects, and mediators and modera-
tors of response will be investigated. Our primary out-
come measure is based on a clinical interview conducted
by independent observers with both the adolescent and
a (non-involved) social worker. In doing so, we gather
comprehensive information that does not rely on a sole
source and combines interview information, file infor-
mation and clinical judgement to reach a final conclusion.
Furthermore, the fact that we continuously collect neuro-
biological and neuropsychological data presents a major
advantage because we will subsequently be able to
combine and compare these objective indicators with the
clinical data collected. Procedurally, the randomised AB-
BA design is a further benefit because it will enable us to
assess within-institution effects. This point is of particular
importance because youth welfare institutions vary ex-
tremely with regard to size, type of population served, or-
ganisational and structural aspects, financial resources,
and professional training opportunities. The automated
online randomisation procedure is clearly defined and re-
flects the study design. The statistical analysis takes the
different study centres and institutions into account. Fur-
thermore, a strong advantage of the present study is the
3-month follow-up period to investigate long-term effects
of the intervention.
Limitations
A limitation of this study lies in the fact that a blind as-
sessment can be realised only during baseline assess-
ment. At post-assessment and follow-up, participants
and other informants included in the assessments (social
workers and adolescents) are aware of the condition they
are in, and thus their evaluation may be biased. How-
ever, to overcome potential bias with regard to the pri-
mary outcome measure, the interview assessing CD/
ODD symptoms will be conducted with social workers
who are not involved in the training. In addition, to as-
sess main secondary measures of emotion processing,
objective neurobiological indicators are used which are
not influenced by expectation effects.
Trial status
In January 2015, the first group was randomised.
Recruitment is expected to be finished by January 2017.
Additional files
Additional file 1: Example informed consent form used at the Basel
site. (PDF 194 kb)
Additional file 2: SPIRIT 2013 Checklist. (DOC 121 kb)
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